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Abstract: Cell viability is defined as the number of healthy cells in a sample and proliferation of cells is 
a vital indicator for understanding the mechanisms in action of certain genes, proteins and pathways in-
volved cell survival or death after exposing to toxic agents. Generally, methods used to determine vi-
ability are also common for the detection of cell proliferation. Cell cytotoxicity and proliferation assays 
are generally used for drug screening to detect whether the test molecules have effects on cell prolifera-
tion or display direct cytotoxic effects. Regardless of the type of cell-based assay being used, it is im-
portant to know how many viable cells are remaining at the end of the experiment. There are a variety 
of assay methods based on various cell functions such as enzyme activity, cell membrane permeability, 
cell adherence, ATP production, co-enzyme production, and nucleotide uptake activity. These methods 
could be basically classified into different categories: (I) dye exclusion methods such as trypan blue dye 
exclusion assay, (II) methods based on metabolic activity, (III) ATP assay, (IV) sulforhodamine B as-
say, (V) protease viability marker assay, (VI) clonogenic cell survival assay, (VII) DNA synthesis cell 
proliferation assays and (V) raman micro-spectroscopy. In order to choose the optimal viability assay, 
the cell type, applied culture conditions, and the specific questions being asked should be considered in 
detail. This particular review aims to provide an overview of common cell proliferation and cytotoxicity 
assays together with their own advantages and disadvantages, their methodologies, comparisons and in-
tended purposes. 
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1. INTRODUCTION 
 Cell viability is the number of living cells in a certain 
population and measuring the amount of proliferating cells is 
used as a vital indicator for action of the cell survival or 
death in response to drugs or chemical agents. The effects of 
a drug can come up as either cytotoxic, which refers to being 
toxic and killing the cells or cytostatic, that is defined as in-
hibition of cell growth. For different types of biological stud-
ies, it is important to detect viable cell number in a certain 
population. Cell cytotoxicity and proliferation assays are 
basically used for screening the response of the cells against 
a drug or any chemical agent. Especially pharmaceutical 
industry widely use cytotoxicity assays to determine the ef-
fects of developed agents on the cells. Researchers use dif-
ferent types of assays in order to screen the outcome of a 
developed therapeutics that target mostly cancer cells.  
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 There are a variety of methods for detecting cytotoxic 
and cytostatic effects of different compounds and measuring 
cellular viability. Different methods could rely on various 
cellular functions including, cell membrane permeability, 
dye uptake, metabolic activities, enzyme releasing, cell ad-
herence, ATP production, co-enzyme production, DNA syn-
thesis and nucleotide uptake activity. The major and com-
mon cell proliferation and cytotoxicity detection methods are 
classified into different categories. 
 Trypan blue, a dye exclusion method, is easier to use 
than all the others, and basically based on staining dead cells 
over living cells. There are different types of metabolic cell 
proliferation assays such as MTT, XTT, MTS, WST1, Ala-
mar Blue, calcein AM, LDH release assay and G6PD release 
assay, which are widely used for screening the cytotoxic 
effects of drugs. On the other hand, the methods based on 
DNA synthesis or cell proliferation markers such as H3 
thymidine uptake, BrdU, PCNA, phosphohistone H3 or Ki-
67 detection are extensively used. In addition to all these 
assays, ATP assay, protease viability marker assay, clono-
genic cell survival assay, sulforhodamine B assays and ra-
man micro-spectrometry are the other common and efficient 
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methods for detecting cell viability. However, all these as-
says should be considered according to the purpose of the 
study, conditions or cell types. All these types of assays are 
detailed in below together with their own advantages and 
disadvantages, their methodologies, comparisons and in-
tended purposes (Table 1). 
2. TRYPHAN BLUE 
 Dye exclusion methods are based on the usage of differ-
ent dyes that living cells can exclude but dead cells could 
not, since living cells with intact cell membrane are highly 
selective to the passage of molecules through their mem-
brane [1]. Tryphan blue is a negatively charged, ~960 
Daltons diazo-dye, which can enter into only damaged mem-
branes and absorbed by dead cells. This dye can be used in 
either in vitro, such as cell cultures or in vivo, such as ob-
serving cancer cell populations in a living organism [2]. It is 
also useful for comparing number of viable cells or prolifera-
tion rates under certain conditions, between two or more 
groups. Tryphan blue is frequently used in the laboratories 
for cell counting under the microscope based on the fact that 
dead cells turn blue after dye application and living cells are 
not be stained, having a clear appearance. Although there are 
many advantages including cheap and easy application, 
apoptosis or necrosis can not be distinguished by this method 
and it has very limited sensitivity as compared to other de-
veloped assays [2].  
3. METABOLIC CELL PROLIFERATION ASSAYS 
3.1. MTT Assay 
 MTT assay is based on the conversion of MTT ((3-[4,5-
dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) to 
insoluble formazan crystals by mitochondrial NAD(p)H-
dependent oxidoreductase enzymes released in living cells 
(Fig. 1). These mitochondrial enzymes have capability to 
convert MTT into insoluble formazans by reduction reaction 
under certain cell culture conditions. MTT assay basically 
leads us to determine the number of viable cells by measur-
ing mitochondrial activity, which is related with the amount 
of formazan crystals [3]. Proliferating cells possess higher 
rate of MTT converting reaction while dead or slow growing 
cells have low metabolism resulting in lower levels of MTT 
reduction. After MTT application, formazan crystals are 
solubilized with a solution such as dimethyl sulfoxide or 
detergent sodium dodecyl sulfate. Therefore, formazan con-
centrations can be measured by a spectrophotometer at be-
tween 540 to 720 nm [3, 4].  
 The most common use for MTT assay is to detect cyto-
toxic effects of different agents under different conditions or 
different concentrations. It is also possible to detect IC50 
value (50% half maximal inhibitory concentration) of ap-
plied drugs by comparing the viability of control group and 
drug applied group [5]. MTT assay is suitable for in vitro 
trials of potential drugs and also to study drug resistance in 
the cell lines. It also helps to determine drug effects in vitro 
and prediction for clinical applications. On the other hand, it 
is not convenient for follow-up studies since it needs to kill 
all the cells during protocol. It is also not possible to distin-
guish cytotoxic and cytostatic agents by this method and 
results would not be proper when the cell number is low  
[5, 6].  
3.2. XTT Assay  
 As MTT, XTT (2,3-bis (2-methoxy-4-nitro-5-
sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazo-lium 
hydroxide) is also a tetrazolium salt, which represents a col-
orimetric assay to study cellular viability. This method is 
also based on the reduction of XTT by mitochondrial NADH 
enzymes converting XTT to formazan crystals [7, 8]. XTT 
assay causes the generation of a water-soluble type of forma-
zan crystals that distinguishes the XTT assay from MTT 
assay. The formazan crystals can be solubilized directly in 
culture medium, thus the additional solubilization step of the 
procedure would be removed [8]. XTT is easier to use than 
MTT assay and it is also more suitable for fungal studies. 
Also, it was suggested that XTT is more sensitive than MTT, 
and has a larger usage range as compared to other tetra-
zolium based assays [7].   
3.3. MTS Assay 
 MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymetho-
xyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) is another tetra-
zolium salt, described after MTT and XTT compounds. 
MTS, in the presence of phenazine methosulphate (PMS), an 
electron-coupling agent, is reduced to formazan crystals by 
mitochondrial reductase enzymes in living cells. The reduced 
formazan crystals are water-soluble, which are dissolved in 
cell culture medium directly and eliminate the usage of any 
extra solution or washing step [7]. Formazan crystals can be 
measured spectrophotometrically at 490-500 nm. MTS rea-
gent solution has more storage stability comparing to MTT 
or XTT compounds although it needs confirmation with 
qualified microscope observation. This assay is useful for 
detecting cell viability in response to drugs, various types of 
cytokines, growth factors, cytotoxic drugs and anticancer 
agents [7, 9].  
3.4. Water Soluble Tetrazolium Assay 
 Water Soluble Tetrazolium (WST) salts have been devel-
oped as a new generation compounds for cell viability assays 
that produce formazan crystals by mitochondrial NADH 
enzymes in living cells. WST-1 and WST-8 (2-(2-methoxy-
4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-
tetrazolium) contain an iodine residue and stay more stable 
in the presence of PMS comparing to XTT or MTS [10]. The 
WST compounds can also be reduced outside the cell when 
they are combined with PMS electron mediator and give more 
efficient spectrophotometric signal than MTT and XTT. WST 
assays do not need any additional step to wash or solubilize 
the formazan crystals, and it is marketed as ready-to-use so-
lution making the whole protocol more rapid [10, 11].  
3.5. Alamar Blue 
 Alamar Blue also known as resazurin is a non-toxic cell 
permeable vital dye. Upon entering into the cell, it is reduced 
to resorufin, which is red in color and highly fluorescent 
since they maintain a reducing environment within the cytosol. 
Higher reduction rate of resazurin to resorufin in proliferating
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Table 1. The cytotoxicity/proliferation assays mentioned in this review together with their working principle, advantages and dis-
advantages. 
Method Principle of Action Advantages Disadvantages 
Tryphan Blue Membrane integrity 
Widely used 
Inexpensive 
Easy to apply 
Apoptosis or necrosis can not be distinguished 
Limited sensitivity 
MTT 
XTT 
MTS  
WST 
Mitochondrial activity 
Widely used 
Inexpensive 
Proper for potential drug follow-up studies 
Long time incubation 
Steps in protocol (MTT) 
Toxic to cell 
Not suitable for long-term studies 
Limited sensitivity 
Work with high cell numbers 
Can not differ cytotoxic or cytostatic 
Alamar Blue Cell metabolism 
Lower toxicity 
Inexpensive 
High sensitivity 
Suitable for long-term studies 
Highly stable in the culture medium 
Fluorescence interference 
Need long optimization procedure 
Can not differ cytotoxic or cytostatic 
Calcein AM Cell metabolism 
Non-radioactive 
Rapid process 
Proper for high-throughput studies 
Not very sensitive in adherent cells 
Need higher sensitive microscopy 
LDH Release 
Assay 
Cell membrane integrity & 
Cell metabolism 
Widely used an Accepted 
Absorbane or fluorescent options 
Low sensitivity 
Not suitable for long-term studies 
False positive results 
G6PD Release 
Assay 
Cell membrane integrity & 
Cell metabolism 
More sensitive than LDH 
More efficient than LDH 
Short term protocol 
Time-consuming 
Not suitable for long-term studies 
ATP Assay ATP production 
Short term protocol 
Very good sensitivity 
Large usage areas 
Can not differ cytotoxic or cytostatic 
Sulforhodamine 
B Assay 
Cellular protein content 
Suitable for high-throughput screening 
Proper for long-term studies 
High sensitive in low cell numbers 
Can not differ living or dead cells 
Protease Viability 
Marker Assay 
Differential protease activity 
Excellent correlation with established methods 
Combatible with downstream applications 
Non-toxic 
Short incubation time 
Differ living or dead cells 
No significant advantages 
Clonogenic Cell 
Survival Assay 
 
Proliferation ability of the cell 
Suitable for long-term cytotoxicity screening 
Consider reversible damage or resistance against 
agents 
Limited dynamic range 
Not suitable to test the impacts of agents that 
do not target DNA synthesis 
H
3
 Thymidine 
Uptake 
DNA replication No significant advantages 
Harmful effects 
Difficulties in handling 
Time-consuming 
BrdU DNA replication 
Reduced equipment and time 
Suitable with simultaneous techniques 
Harsh labelling conditions 
Potential carcinogen 
Ki-67 Antigen 
DNA replication and cell 
division 
All phases of the cell cycle and mitosis detected 
Not suitable for formalin-fixed paraffin sec-
tions 
PCNA Detection DNA replication No detrimental effect on histological architecture 
Variations in signal intensities 
PCNA’s longer half life 
Phospho-Histone 
H3 Detection 
Cell division All four stages of mitosis detected Time-consuming 
Raman Micro-
Spectrometry 
Interaction of electromagnetic 
radiation with the sample 
molecule 
Very rapid 
Non-invasive 
No damage to the cells 
No significant advantages 
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cells and lower rate of this reduction in dead cells could be a 
marker to distinguish cellular viability. Dead or damaged 
cells would create lower fluorescence changes since they are 
lack of cellular metabolism [12]. The metabolic reactions 
generating fluorescence signals can be measured at 570 and 
630 nm.  
 This method can be preferred since it causes lower toxic-
ity than the other methods and most importantly this dye can 
be used to conduct long-term experiments without killing the 
cells [13]. Also, resazurin is a non-radioactive, water-soluble 
molecule that has high stability in the cell culture. On the 
other hand, using resazurin may require very long experi-
mental optimization time that decreases its convenience for 
rapid assays. In some cases, it causes fluorescence interfer-
ences, which may cause false results [14].  
3.6. Calcein-AM 
 Although calcein is a type of fluorescent dye, being de-
tected at 495/515 nm wavelength, its non-fluorescent deriva-
tive calcein-acetomethoxy (Calcein AM) is commonly used 
in cytotoxicity assays [15]. Calcein AM can pass the mem-
brane in both living and damaged or dead cells with the help 
of its lipid soluble feature. After the transport of calcein AM 
into the cells, cytoplasmic esterases remove its acetomethoxy 
group and calcein give a strong green fluorescent signal [15, 
16]. Cytoplasmic esterases can not be activated in dead or 
damaged cells, and thus only living cells are stained with 
calcein and the signal they give out can be measured rapidly 
in a sensitive manner by flow cytometry. Calcein assay is 
useful for clinical laboratory procedures and it is described 
as a quantitative, standardized, easy to use and inexpensive 
method. Up to now, it was shown that calcein AM assay can 
be used in drug resistance studies such as P-glycoprotein and 
multidrug resistance protein activities, drug-drug interactions 
as well as red blood cell and aging studies. On the other 
hand, it is known that this assay is not proper for adherent 
cells because the adherence can block the passage of calcein 
into the cells [16, 17].  
3.7. Lactate Dehydrogenase Release Assay  
 Lactate dehydrogenase release assay was first developed 
to determine cytotoxicity in immune cells. LDH is a soluble 
cytoplasmic enzyme released into the cell culture medium 
after membrane disruption in necrotic or apoptotic cells [18]. 
Therefore, LDH activity can be measured to detect the cyto-
toxic effects of different agents or environmental factors. 
LDH assay includes 2-step procedure to measure the level of 
LDH activity in cell culture medium. In the first step, LDH 
catalyzes the conversion of lactate to pyruvate via reduction 
of NAD+ to NADH. Then, this step is followed by the re-
duction of a tetrazolium salt (INT) to a red formazan product 
by diasphorase enzymes using generated NADH [4, 19] (Fig. 
2). Lastly, appeared tetrazolium salt can be measured col-
orimetrically at 490-520 nm by a spectrophotometer. There-
fore, the level of formazan formation is directly proportional 
to the amount of released LDH in the medium. The LDH 
level in the culture medium can be contaminated by endoge-
nous LDH activity and cause false positive results, suggest-
ing additional confirmations are needed with this method. 
Although this method is used widely and accepted, LDH 
half-life in the culture medium is limited and the sensitivity 
of LDH assay is also limited [19, 20].  
 
 
 
Fig. (2). LDH release assay. LDH released from damaged or dead 
cells catalyzes the oxidation of lactate to pyruvate while catalyzing 
NAD+ reduction to NADH molecule. The resulting NADH is used 
by Diaphorase enzyme to transform INT (tetrazolium salt) to red 
formazan crystals, which is measured colorimetrically. 
 
3.8. Glucose-6-phosphate Dehydrogenase Release Assay 
 Glucose-6-phosphate dehydrogenase (G6PD) assay is 
also a fluorescence based cell viability assay. This assay is 
based on the releasing of cytosolic enzyme, G6PD, from 
damaged cell membrane to the culture medium in dead cells. 
G6PD is involved in pentose phosphate pathway and respon-
sible for generating NADPH from NADP+ in the mitochon-
dria. Exogenously added resazurin can be reduced to re-
sorufin, which is a highly fluorescent dye, in the presence of 
generated NADPH. G6PD assay is based on measuring the 
amount of fluorescent signal to determine the concentration 
of dead cells in the population. G6PD assay is more sensitive 
comparing to LDH. Moreover, it was shown that background 
signals in G6PD assay are lower than LDH assay, which 
confirm the efficiency of this assay. On the other hand, 
 
 
Fig. (1). MTT assay. Mitochondrial NADH is converted to NAD+ 
via dehydrogenase. This reaction causes the reduction of yellow 
tetrazolium salts (MTT, XTT, MTS and WST) to purple formazan 
crystals in living cells. 
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G6PD release assay can be completed in a very short time as 
compared to other enzyme release assays [14].  
4. ADENOSINE 5’-TRIPHOSPHATE ASSAY 
 Adenosine 5’-triphosphate (ATP) is the major energy 
source of living organisms and mostly produced in mito-
chondria. ATP and its phosphate bond supply the energy to 
complete all the energy requiring processes in the cells. 
Measurement of total cellular ATP levels can lead to deter-
mining cell viability or cytotoxic effects of different agents 
on the cells [21].  
 ATP assay is based on monitoring of ATP levels via bio-
luminescent detection. Added natural firefly enzyme lu-
ciferase and luciferin react with cellular ATP and cause the 
production of certain level of light that is measured by a Lu-
minometer (Fig. 3). The amount of luminescent light is di-
rectly proportional to the viability of cells [21, 22]. ATP as-
say is advantageous comparing to other methods with differ-
ent ranges such as short time protocol, high sensitivity and 
large usage areas. The signal is also present for a long time 
of period that makes the measuring step easier. But it is not 
possible to differentiate cytostatic or cytotoxic effects of 
drugs since the decrease in ATP level could depend on cell 
number, cell death or metabolic activities [4]. On the other 
hand, it was shown that ATP assay is more accurate than all 
other assays in terms of predicting the resistance or sensitiv-
ity of platinium-resistant epithelial ovarian cancer tumors to 
other agents [23].  
 
 
 
Fig. (3). The principle of ATP assay. Exogenously added luciferin 
is turned into oxy-luciferin by luciferase enzyme with a reaction 
involving cellular ATP. The oxy-luciferin producing strong fluores-
cent light is captured and measured by a Luminometer. 
 
5. SULFORHODAMINE B ASSAY  
 Sulforhodamine B (SRB) (C27H30N2O7S2) assay was 
developed by Skehan et al. for measurement of in vitro cyto-
toxicity, proliferation and drug screening. SRB assay is 
based on the binding of SRB dye to all protein components 
via their basic amino acid residues of trichloroacetic acid 
(TCA) fixed cells under mild acidic conditions. SRB dye is 
an anionic bright-pink aminoxanthene and has two sulfonic 
groups that are capable of binding basic amino acids electro-
statically and pH dependently [22, 24]. Then, associated 
SRB dye can be solubilized from the cells using weak bases 
and measured spectrophotometrically at 490-550nm. The 
amount of SRB concentration is directly proportional to the 
number of living cells.  
 It was shown that the SRB assay is highly sensitive even 
to detect the optic density (OD) value of 1,000-2,000 cells 
[22]. Moreover, it is known that SRB assay is more practical 
than the other methods because the cells can be stored as 
long as required after TCA fixation and SRB staining. SRB 
assay exhibits the same performance level comparing to 
MTT or clonogenic assays when the test is limited to IC50 
value of the agent. On the other hand, MTT requires cellular 
activity to exhibit the results and it detects the living cells 
while SRB can not differentiate living or dead cells but just 
represent the data of total protein amount which can be used 
as a factor to measure living cells. Once the protocol has 
been optimized, the SRB assay can used for high-throughput 
screening applications by the help of automated equipments 
[24, 25].  
6. PROTEASE VIABILITY MARKER ASSAY 
 Mammalian cells in the culture have a great diversity in 
terms of enzymes such as proteases which are involved in 
several cellular processes like intracellular protein degrada-
tion and cell division and grouped into cytoplasmic, lysoso-
mal and transmebrane-bound proteases. The activities of 
proteases are regulated by distinct mechanisms such as 
unique compartmentalization [26]. Therefore, a protease 
viability assay is developed based on the detection of differ-
ential ubiquitous proteolytic activities associated with intact 
viable cells and cells that have lost membrane integrity. The 
release of stable protease activity into the medium and the 
measure of constitutive proteolytic enzymes could allow 
simultaneous measurement of the relative number of viable 
or dead cells in a cell culture population [27].  
 Recently, the measurement of a conserved and constitu-
tive protease activity within live cells has been developed as 
a marker of cell viability. A fluorogenic cell permeable pro-
tease substrate (glycyl-phenylalanyl-aminofluorocoumarin; 
GF-AFC) has been used to selectively detect protease activ-
ity in viable cells. The glycine and phenylalanine amino ac-
ids are removed from the GF-AFC by cytoplasmic amin-
opeptidase activity to release aminofluorocoumarin (AFC) 
when the GF-AFC substrate penetrates into live cells, and 
thus generating a fluorescent signal proportional to the num-
ber of viable cells [27]. The protease responsible for the 
cleavage of the GF-AFC substrate becomes inactive as soon 
as the cells die. On the other hand, a second protease is re-
leased into the medium from dead cells since they have lost 
membrane integrity. This protease activity is measured using 
a nonpermeable fluorogenic peptide substrate (bis-
alanylalanyl-phenylalanyl-rhodamine 110; bis-AAF-R110). 
Because the AAF-R110 substrate is nonpermeable and can-
not enter to viable cells, the signal from this substrate is se-
lective for the dead cell population [27, 28].  
 In methodology, the GF-AFC and AAF-R110 substrates 
can be added together as a single reagent to cells in culture 
and incubated for 30 minutes to generate fluorescent signals 
that are proportional to the number of viable and dead cells 
[28]. 
 This viability assay has important advantages: I) The 
viable and dead cell protease markers show excellent corre-
lation with established methods such as measurement of 
ATP and release of lactate dehydrogenase, II) The GF-AFC 
and AAF-R110 substrates are compatible with other reagents 
involved in additional downstream applications to measure 
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other parameters, such as gene expression or caspase activ-
ity, III) The GF-AFC substrate is relatively non-toxic to cells 
in the culture even when the cells are exposed to the GF-
AFC for longer times and longer exposure results in only 
very small changes in the viability, IV) The incubation time 
required to measure a signal is much shorter (about 30 min to 
1 hour) than the tetrazolium assays (1 to 4 hours) [29, 30]. 
7. CLONOGENIC CELL SURVIVAL ASSAY 
 The clonogenic cell survival assay or colony formation 
assay is based on the ability of a cell to proliferate to form a 
large colony or a clone. This cell is then said to be clono-
genic. A cell survival curve is designed based on a relation-
ship between the dose of the agent used and the proportion of 
cells retaining their ability to reproduce [31]. Although this 
method is used as a first choice to study the effects of radia-
tion on cells, it is now commonly used to determine the ef-
fects of other cytotoxic agents [32]. To study the effects of 
various agents alone or in combination, most laboratories 
commonly use established cell lines for clonogenic cell sur-
vival assay. 
 In methodology, cell suspension is prepared by deattach-
ing the cells from an actively growing stock culture in mono-
layer and the number of cells per milliliter in this suspension 
is then counted using a hemocytometer. Before or after 
treatment, the appropriate number of the cells are seeded into 
a dish and incubated to form colonies in 1 to 3 weeks. Each 
single cell divides many times and forms a colony. Colonies 
are fixed with glutaraldehyde, stained with crystal violet, and 
counted using a stereomicroscope. Then, the plating effi-
ciency (PE), the percentage of cells seeded into a dish that 
finally grow to form a colony, is calculated for both treated 
and untreated control cells [31, 32].  
 Various non-clonogenic cytotoxicity and cell survival 
assay can be used to measure the potency of a cytotoxic 
agent, however these short-term assays can underestimate 
cytotoxicity as compared to long-term cell growth assays. On 
the other hand, non-clonogenic cytotoxicity assays can 
sometimes overestimate cytotoxicity due to not considering 
reversible damage or regrowing of resistant cells against the 
cytotoxic agent. For these reasons, it may be suggested to 
use clonogenic cell survival assays [4]. 
 The clonogenic cell survival has some limitations as 
well: I) It lacks dynamic range (the ratio between the largest 
and smallest possible values of a changeable quantity) of 
fluorescent methods or the ATP assay [4, 33], II) It can not 
measure the effects of cell to cell communication on cell 
proliferation due to low density of the cells plated, III) This 
assay is not suitable to test the impacts of agents that de-
crease growth without inhibiting DNA synthesis and/or cell 
cycle progression and the agents that inhibit growth only by 
causing cytoskeletal damage or by inducing apoptosis [34, 
35]. 
8. METHODS FOR DETECTING DNA SYNTHESIS 
AND CELL PROLIFERATION MARKERS 
 Cellular division and DNA replication are fundamental 
biological activities, which play important roles in both 
physiological and pathological processes. It is important to 
know when S phase (DNA synthesis) occurs precisely in the 
cell cycle in order to maximize the tumor killing effects of 
anticancer drugs targeting cell cycle [36]. Therefore, the data 
obtained from cell kinetic data gives valuable information 
after treatment, especially in many cancer types. In this con-
text, the use of monoclonal antibodies against specific cell 
proliferation-associated antigens is the most common ap-
proach. These antibodies could detect either endogenous 
molecules or exogenous substances which can be taken up 
by cells at specific stages during the cell cycle [37].  
8.1. Tritium Labeled (H
3
) Thymidine Uptake 
 The original approach to detect mitotically active cells 
included the incorporation and detection of tritium labeled 
(H3) thymidine using autoradiography or scintillation tech-
niques. Tritium labeled (H3) thymidine and autoradiography 
were originally developed as DNA probes to prove that DNA 
replication is a semi-conservative manner [36]. This method 
has harmful effects, including DNA fragmentation, cell cycle 
arrest, chromosomal aberrations, and induction of apoptosis 
[38]. Moreover, difficulties in handling radiolabeled sub-
strate, the time-consuming nature of this technique and the 
detection of the cells only in the S phase resulted in the de-
velopment of new techniques to label nascent DNA, which 
was facilitated by advances in the production of monoclonal 
antibodies [39]. 
8.2. 5-bromo-2-deoxyuridine (bromodeoxyuridine or 
BrdU)  
 DNA synthesis can be detected by measuring the incor-
poration of the thymidine analogue, bromodeoxyuridine 
(BrdU), in place of thymidine during the S phase of the cell 
cycle. Therefore, this nucleoside analog becomes an excel-
lent marker of cell cycle and proliferation. The development 
of a specific antibody against BrdU provided an opportunity 
for immunological detection of the newly synthesized BrdU-
incorporating DNA.  
 BrdU method has numerous advantages over tritium la-
beling such as significantly reduced equipment and time. 
This method enables the use of several simultaneous tech-
niques and processes such as cell fate and lineage analysis 
using cell specific markers as well [39]. As well as its advan-
tages, there are a number of limitations in its utility. For in-
stance, the detection of BrdU following its incorporation into 
DNA needs the denaturation of DNA to allow BrdU specific 
antibody binding and the cell and nuclear membranes have to 
be permeabilized for antibody access. However, these harsh 
labeling conditions could cause cell disruption together with 
protein and nucleic acid degradation, which limit the use of 
this method if simultaneous measurement of protein content 
or molecular analysis is required. [40]. Moreover, research-
ers working with BrdU should be careful because it is classi-
fied as a potential carcinogen. Despite these negative out-
comes, BrdU has remained the first choice to study cell pro-
liferation.  
 At present, there are several ways suitable for both ad-
herent and suspension cells that allow the quantification of 
BrdU incorporation into the newly synthesized DNA of ac-
tively proliferating cells such as colorimetric and chemilu-
minescent options based on the method of choice [41, 42]. 
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As well as these approaches, BrdU incorporation may be 
quantitated by flow cytometry or immunohistochemistry. 
However, the use of flow cytometry is limited to cell suspen-
sions, thus it is not suitable to detect the localization of spe-
cific S phase cells in tissue samples. Immunohistochemical 
techniques-related detection of BrdU incorporation is appro-
priate for S phase cells [39, 40]. 
8.3. Detection of Ki-67 Antigen 
 Ki-67 is a nuclear antigen associated with the cell cycle. 
A detailed cell cycle analysis displayed that the antigen was 
expressed in all phases of the cell cycle (G1, S, and G2 
phases) and mitosis. However, quiescent or resting cells in 
the G0 phase did not express Ki-67 antigen [43]. Although 
the exact function of Ki-67 antigen during the cell cycle is 
unknown, there is a close link between its protein expression 
and proliferation. Because, the Ki-67 antigen is found in all 
proliferating cells including normal and cancer cells, the 
presence of this structure is an excellent marker to determine 
the fraction of growing cells in a population. Therefore, anti-
bodies against the Ki-67 protein are widely used in cancer 
research [44]. The percentage of cells staining positive for 
the Ki-67 antigen is called the Ki-67 index and it is directly 
related to cell proliferation. The Ki-67 index may give an 
idea about the growth characteristics of a tumor and the ef-
fects of certain drugs on it.  
 The Ki-67 index is more sensitive as compared to the 
determination of the cellular DNA content by flow cytome-
try and in vitro labeling of newly synthesized DNA since the 
Ki-67 antibody recognizes cells in all active phases of the 
cell cycle [44]. 
 The Ki-67 staining protocols show variation based on its 
detection method. It could be detected using flow cytometry-
related approach or colorimetric approach. In both methods, 
the cells are fixed and become permeabilized. Then, anti-Ki-
67 antibody is added to the cells. Based on the feature of Ki-
67 antibody, a secondary antibody recognizing the Ki-67 
antibody is added and then analysis is performed [45,46]. 
Additionally, immunostaining of Ki-67 antigen on various 
types of cytological and histological preparations provides a 
great opportunity to count immune histologically stained 
nuclei. However, the original human Ki-67 antibodies are 
not suitable for formalin-fixed paraffin sections that are com-
monly used in histopathology and these antibodies have lim-
ited cross-species reactivity. However, these drawbacks have 
been solved by producing new monoclonal antibodies named 
as MIB (for Molecular Immunology Borstel), which can 
detect Ki-67 equivalents in several different species such as 
cattle, dog, horse, sheep and rodents and can be used with 
formalin-fixed, paraffin-embedded tissue [44]. 
8.4. Proliferating Cell Nuclear Antigen Detection 
 Proliferating cell nuclear antigen (PCNA) is an evolu-
tionarily well-conserved 36-kDa protein, which was firstly 
identified as a processivity factor of DNA polymerase δ re-
quired for DNA synthesis during replication. PCNA provides 
processivity through association with various DNA replica-
tion associated proteins. On the other hand, PCNA is in-
volved in many other important cellular processes such as 
DNA repair, chromotain remodeling and cell cycle control 
[47]. It is known that PCNA synthesis begins in the late G1 
phase, makes a peak during the S phase, declines in G2 and 
is virtually absent in the M phase [48]. Therefore, PCNA is 
often used as a marker for cell proliferation due to its vital 
roles in DNA replication.  
 Several monoclonal antibodies against PCNA have been 
developed such as 19A2 and PC10 that are commercially 
available. These antibodies are used to detect PCNA based 
on their specific features by using various techniques such as 
immunofluoresence staining of fixed cells, immunohisto-
chemical analysis of formalin-fixed, paraffin-embedded tu-
mor tissues and flow cytometry [49]. At present, there are 
also commercial PCNA elisa kits for nuclear and whole cell 
extracts. 
 A major advantage of using PCNA antibodies is that they 
can be applied to fixed tissue without any detrimental effect 
on histological architecture [50]. The major limitations of 
this technique are varied staining intensities of nuclei, de-
pendence of staining on fixation method (methanol fixation 
results in the labeling of cells in S phase, whereas other types 
of fixation permit the staining of all cycling cells) and 
PCNA’s longer half life (20 hour, it can be expressed even 
when the cells reach G0) are [51]. 
8.5. Phospho-Histone H3 Detection 
 Phospho-Histone H3 (pHH3) is a recently described pro-
liferation marker and it is specific for all four stages of mito-
sis [52]. The phosphorylation of histone H3 plays an impor-
tant role in gene expression, chromatin remodeling, chromo-
some condensation and cell division. It is known that histone 
H3 phosphorylation may occur at different phases of cell 
division depending on different organisms. However, meta-
phase chromosomes are always found to be heavily phos-
phorylated [53]. H3 phosphorylation at serine 10 and serine 
28 is coupled with mitotic chromosome segregation and 
condensation [54]. Development of anti-pHH3 antibody 
makes the immunohistochemical detection easier in cells and 
tissues. Therefore, pHH3 staining may be a useful method in 
which accurate determination of proliferation potential is 
relevant to tumor grading or clinical treatment decision-
making [54].  
 In a current protocol, antigen detection in tissues and 
cells is a multi-step immunohistochemical process. The ini-
tial step involves the binding of the primary antibody to its 
specific epitope. After this labeling, an enzyme labeled 
polymer is added to bind to the primary antibody. The detec-
tion of the bound antibody is performed by a colorimetric 
reaction [55]. 
9. RAMAN MICRO-SPECTROSCOPY 
 Most of the techniques described in the literature are in-
vasive and require additional steps such as cell fixation, 
staining or protein extractions. Raman microscopy is used to 
distinguish cells at different stages of cell cycle and living 
cells from dead cells as a non-invasive method. The working 
principle of raman spectroscopy includes the interaction of 
electromagnetic radiation with the sample molecules and 
represents a chemical fingerprint of the sample [56]. This 
technique has three main advantages over conventional  
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biological assays when applied to the study of living cells: I; 
it is very rapid (1 to 3 min), II) no labels are required so it is 
non-invasive, and III) no damage is induced to the cells if 
suitable laser wavelength and intensities are used [57]. Ra-
man spectroscopy has been shown to analyze in situ and real 
time biochemical changes in living cancer cells treated with 
toxic chemical agents [58]. In a recent study, the effect of 
cisplatin on A549 human lung adenocarcinoma cells was 
investigated with raman spectroscopy. The results were 
compatible with MTT cytotoxicity assay [59]. 
10. CONCLUSION 
 The measurement of cell viability has a significant and 
fundamental role in all cell culture studies. Cell cytotoxicity 
and proliferation assays are generally used for drug screen-
ing to detect whether the test molecules have effects on cell 
proliferation or display direct cytotoxic effects. Regardless 
of the type of cell-based assay being used, it is important to 
know how many viable cells are remaining at the end of the 
experiment. There are wide arrays of cell viability methods 
ranging from the most routine tryphan blue dye exclusion 
assay to highly complex analysis of individual cells, such as 
using Raman microscopy. In order to choose the optimal 
viability assay, the cost, speed, and complexity of equip-
ment, the cell type, culture conditions, the specific questions 
being asked should be considered in detail. Regardless of the 
assay method, there are major critical factors that should be 
considered for reproducibility and success: I) experiments 
should be performed with tightly controlled and consistent 
source of cells and II) drug/agent/reagent concentration and 
incubation time should be optimized for each experiment. 
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